Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bai'ai capsule for hypertension associated with metabolic syndrome
ChiCTR-TRC-14004782Phase 4Recruiting
- Sponsor
- Huashan Hospital
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Bai'ai capsule in hypertension (HTN) and cardiometabolic risk (CMR) (2 arms), sponsored by Huashan Hospital. Primary endpoints: Blood pressure and 24-hour ambulatory blood pressure. Started Jan 2014; status: recruiting.
02
Drugs
Bai'ai capsule
03
Conditions
hypertension (HTN)cardiometabolic risk (CMR)
Beyond the preview
Go deeper on ChiCTR-TRC-14004782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004782.